Sarepta Therapeutics (SRPT) Announces Restructuring and ELEVIDYS Black Box Warning, EMA Recommends Refusal of Marketing Authorization, Securities Class Action Pending - Hagens Berman
Go back to Sarepta Therapeutics (SRPT) Announces Restructuring and ELEVIDYS Black Box Warning, EMA Recommends Refusal of Marketing Authorization, Securities Class Action Pending - Hagens Berman| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.11 | 52 Week High | $63.73 | |||
| Open | $20.11 | 52 Week Low | $8.00 | |||
| Day High | $20.11 | P/E | N/A | |||
| Day Low | $20.11 | EPS | $-5.69 | |||
| Volume | 1 | |||||
